JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Last updated: 01 November 2019
FDA approves Tasigna (nilotinib) for certain pediatric patients with Ph+ CML in chronic phase.Read more